Sichuan Goldstone Asia Pharmaceutical (SZSE:300434) Debt-to-Equity : 0.05 (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Sichuan Goldstone Asia Pharmaceutical Debt-to-Equity?

Sichuan Goldstone Asia Pharmaceutical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥116 Mil. Sichuan Goldstone Asia Pharmaceutical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥2 Mil. Sichuan Goldstone Asia Pharmaceutical's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥2,490 Mil. Sichuan Goldstone Asia Pharmaceutical's debt to equity for the quarter that ended in Mar. 2024 was 0.05.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Sichuan Goldstone Asia Pharmaceutical's Debt-to-Equity or its related term are showing as below:

SZSE:300434' s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.01 Max: 0.42
Current: 0.05

During the past 13 years, the highest Debt-to-Equity Ratio of Sichuan Goldstone Asia Pharmaceutical was 0.42. The lowest was 0.00. And the median was 0.01.

SZSE:300434's Debt-to-Equity is ranked better than
94.03% of 134 companies
in the Industrial Distribution industry
Industry Median: 0.51 vs SZSE:300434: 0.05

Sichuan Goldstone Asia Pharmaceutical Debt-to-Equity Historical Data

The historical data trend for Sichuan Goldstone Asia Pharmaceutical's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sichuan Goldstone Asia Pharmaceutical Debt-to-Equity Chart

Sichuan Goldstone Asia Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.01

0.05

Sichuan Goldstone Asia Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.01	0.01	-	0.05	0.05

Competitive Comparison of Sichuan Goldstone Asia Pharmaceutical's Debt-to-Equity

For the Industrial Distribution subindustry, Sichuan Goldstone Asia Pharmaceutical's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sichuan Goldstone Asia Pharmaceutical's Debt-to-Equity Distribution in the Industrial Distribution Industry

For the Industrial Distribution industry and Industrials sector, Sichuan Goldstone Asia Pharmaceutical's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Sichuan Goldstone Asia Pharmaceutical's Debt-to-Equity falls into.

Sichuan Goldstone Asia Pharmaceutical Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Sichuan Goldstone Asia Pharmaceutical's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(112.116	+	2.712)	/	2400.43
	=	0.05

Sichuan Goldstone Asia Pharmaceutical's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(115.922	+	2.287)	/	2490.246
	=	0.05

Sichuan Goldstone Asia Pharmaceutical (SZSE:300434) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Sichuan Goldstone Asia Pharmaceutical Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Sichuan Goldstone Asia Pharmaceutical's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Sichuan Goldstone Asia Pharmaceutical (SZSE:300434) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Distribution » Sichuan Goldstone Asia Pharmaceutical Inc (SZSE:300434) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

8 Jiayuan Road, 8th Floor, District A1, Dadi Xinguanghua Plaza, Chengdu, CHN, 610072

Website

http://www.goldstone-group.com

Sichuan Goldstone Asia Pharmaceutical Inc is engaged in development and application of steel-reinforced plastic composite pipe technology, providing customers with steel-reinforced plastic composite pipes from pipe structure, production process to construction technology. The company is also engaged in research and development, production and sales of medicines and health products.

Sichuan Goldstone Asia Pharmaceutical (SZSE:300434) Headlines

No Headlines